Lung Assessment Device Market Trends

  • Report ID: 5210
  • Published Date: Nov 25, 2025
  • Report Format: PDF, PPT

Lung Assessment Device Market - Growth Drivers and Challenges

Growth Drivers

  • Escalating Prevalence of Respiratory Disorders – The escalating incidence of respiratory disorders, such as asthma, chronic obstructive pulmonary disease (COPD), and lung infections, is a driving force behind the expansion of the Lung Assessment Device sector. According to the World Health Organization (WHO), approximately 235 million individuals suffer from asthma globally, and over 3 million deaths are attributed to COPD each year.

  • Growing Emphasis on Early Diagnosis and Prevention: The shift towards proactive healthcare and preventive measures is propelling the demand for lung assessment devices that aid in early diagnosis. Early detection of respiratory conditions allows for timely intervention and better management.

  • Home-based Healthcare and Patient Empowerment: The trend towards home-based healthcare is fostering the development of portable lung assessment devices that empower patients to monitor their respiratory health. This trend is gaining traction, particularly in the wake of the COVID-19 pandemic.

Challenges

  • Technological Complexity and Integration: The rapid evolution of technology, while beneficial, brings forth challenges related to device complexity and seamless integration. Designing and implementing advanced features such as wireless connectivity, real-time data transmission, and user-friendly interfaces require significant engineering expertise. Ensuring compatibility and ease of use across various platforms and devices can be a substantial undertaking.

  • Accuracy and Reliability

  • Regulatory Compliance

Base Year

2025

Forecast Year

2026-2035

CAGR

6.9%

Base Year Market Size (2025)

USD 15.25 billion

Forecast Year Market Size (2035)

USD 29.72 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of lung assessment device is evaluated at USD 16.2 billion.

The global lung assessment device market size was worth around USD 15.25 billion in 2025 and is set to register a CAGR of more than 6.9%, exceeding USD 29.72 billion revenue by 2035.

Across 2026-2035, the Asia Pacific region is forecast to command a 38% revenue share by 2035 in the lung assessment device market, stemming from the escalating burden of respiratory diseases.

Key players in the market include Philips Healthcare, Medtronic, Masimo Corporation, GE Healthcare, BD (Becton, Dickinson and Company), Smiths Medical, Teleflex Incorporated, Fisher & Paykel Healthcare, Nihon Kohden Corporation, CareFusion Corporation.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos